Works matching DE "HEPATITIS A virus cellular receptors"


Results: 264
    1

    Role of galectin-9 in the development of gestational diabetes mellitus.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-03879-8
    By:
    • Albuayjan, Haya Hamed Hassan;
    • Watanabe, Mayu;
    • Sugawara, Ryosuke;
    • Katsuyama, Eri;
    • Mise, Koki;
    • Oi, Yukiko;
    • Kanno, Ayaka;
    • Yang, BoXuan;
    • Tahara, Toshihisa;
    • Nojima, Ichiro;
    • Nakatsuka, Atsuko;
    • Eguchi, Jun;
    • Maki, Jota;
    • Eto, Eriko;
    • Hayata, Kei;
    • Masuyama, Hisashi;
    • Wada, Jun
    Publication type:
    Article
    2
    3

    Evaluation of changes in exhausted T lymphocytes and miRNAs expression in the different trimesters of pregnancy in pregnant women.

    Published in:
    Molecular Biology Reports, 2024, v. 51, n. 1, p. 1, doi. 10.1007/s11033-024-09370-3
    By:
    • Shekarchi, Ali Akbar;
    • Hosseini, Leila;
    • Kamrani, Amin;
    • Alipourfard, Iraj;
    • Soltani-Zangbar, Mohammad Sadegh;
    • Akbari, Morteza;
    • Roshangar, Leila;
    • Aghebati-Maleki, Leili;
    • Chakari-Khiavi, Forough;
    • Chakari-Khiavi, Aref;
    • Motlagh Asghari, Kimia;
    • Danaii, Shahla;
    • Pourlak, Tannaz;
    • Ahmadian Heris, Javad;
    • Yousefi, Mehdi
    Publication type:
    Article
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Common inherited variants of PDCD1, CD274 and HAVCR2 genes differentially modulate the risk and prognosis of adenocarcinoma and squamous cell carcinoma.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2023, v. 149, n. 9, p. 6381, doi. 10.1007/s00432-023-04602-8
    By:
    • Moksud, Nafeesa;
    • Wagner, Marta;
    • Pawełczyk, Konrad;
    • Porębska, Irena;
    • Muszczyńska-Bernhard, Beata;
    • Kowal, Aneta;
    • Wiśniewski, Andrzej;
    • Kosacka, Monika;
    • Kończak, Julia;
    • Karpiński, Paweł;
    • Frydryk, Dominik;
    • Andrzejczak, Anna;
    • Karabon, Lidia;
    • Kuśnierczyk, Piotr;
    • Jasek, Monika
    Publication type:
    Article
    23
    24

    TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 11, p. 3405, doi. 10.1007/s00262-023-03516-1
    By:
    • Sauer, Natalia;
    • Janicka, Natalia;
    • Szlasa, Wojciech;
    • Skinderowicz, Bartłomiej;
    • Kołodzińska, Katarzyna;
    • Dwernicka, Wioletta;
    • Oślizło, Małgorzata;
    • Kulbacka, Julita;
    • Novickij, Vitalij;
    • Karłowicz-Bodalska, Katarzyna
    Publication type:
    Article
    25
    26

    Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients.

    Published in:
    Cancer Immunology, Immunotherapy, 2023, v. 72, n. 1, p. 55, doi. 10.1007/s00262-022-03228-y
    By:
    • Davern, Maria;
    • Donlon, Noel E.;
    • O'Connell, Fiona;
    • Gaughan, Caoimhe;
    • O'Donovan, Cillian;
    • Habash, Mohammed;
    • Sheppard, Andrew D.;
    • MacLean, Michael;
    • Dunne, Margaret R.;
    • Moore, Jenny;
    • Temperley, Hugo;
    • Conroy, Melissa J.;
    • Butler, Christine;
    • Bhardwaj, Anshul;
    • Ravi, Narayanasamy;
    • Donohoe, Claire L.;
    • Reynolds, John V.;
    • Lysaght, Joanne
    Publication type:
    Article
    27
    28
    29
    30
    31
    32
    33
    34

    PD-1 blockade enhances chemotherapy toxicity in oesophageal adenocarcinoma.

    Published in:
    Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-07228-x
    By:
    • Davern, Maria;
    • O' Brien, Rebecca M.;
    • McGrath, Jason;
    • Donlon, Noel E.;
    • Melo, Ashanty M.;
    • Buckley, Croí E.;
    • Sheppard, Andrew D.;
    • Reynolds, John V.;
    • Lynam-Lennon, Niamh;
    • Maher, Stephen G.;
    • Lysaght, Joanne
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43

    TIM-3, LAG-3, or 2B4 gene disruptions increase the anti-tumor response of engineered T cells.

    Published in:
    Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1315283
    By:
    • Cianciotti, Beatrice Claudia;
    • Magnani, Zulma Irene;
    • Ugolini, Alessia;
    • Camisa, Barbara;
    • Merelli, Ivan;
    • Vavassori, Valentina;
    • Potenza, Alessia;
    • Imparato, Antonio;
    • Manfredi, Francesco;
    • Abbati, Danilo;
    • Perani, Laura;
    • Spinelli, Antonello;
    • Shifrut, Eric;
    • Ciceri, Fabio;
    • Vago, Luca;
    • Di Micco, Raffaella;
    • Naldini, Luigi;
    • Genovese, Pietro;
    • Ruggiero, Eliana;
    • Bonini, Chiara
    Publication type:
    Article
    44
    45
    46
    47
    48
    49
    50